Capital increase to US subsidiary JLL Med USA was executed. Increase amount: 10.0 million USD; post-increase capital: 10.4 million USD; equity ownership: 100% and classification as a wholly owned subsidiary. The impact on consolidated results for the fiscal year ending March 2027 is expected to be minimal.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7575","jir_company_name":"Japan Lifeline Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-09-24","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/7575-20260924-01.pdf","jir_short_summary":"Capital increase to US subsidiary JLL Med USA was executed. Increase amount: 10.0 million USD; post-increase capital: 10.4 million USD; equity ownership: 100% and classification as a wholly owned subsidiary. The impact on consolidated results for the fiscal year ending March 2027 is expected to be minimal.","jir_summary":"### Section Heading\nThis matter is a capital policy aimed at strengthening the company\u2019s US footprint as part of mid- to long-term growth strategy to expand global sales. It involves increasing the capital of US subsidiary JLL Med USA Inc. to support agile business deployment in the US market. JLL Med USA develops and sells medical devices. Post-increase, the subsidiary is 100% owned by the company, and the subsidiary\u2019s directors also serve as officers. The subsidiary was established on August 25, 2026.\n\n### Section 2 Heading\nLooking ahead, the impact on consolidated results for the fiscal year ending March 2027 is expected to be minimal, and the aim is to enhance the group\u2019s overall corporate value by strengthening the US market base as part of the global strategy. Note that current settlement figures have not been disclosed in the announced figures.","jir_financial_highlights":"Capital increase amount: 10,000 thousand USD (Unknown)\nCapital after increase: 10,400 thousand USD (Unknown)\nEquity ownership: 100\uff05 (Unknown)","jir_category":"","jir_hashtags":"#JapanLifeline, #CapitalPolicy, #OverseasSubsidiary, #GlobalStrategy","jir_key_figures":"Capital increase amount: 10,000 thousand USD\nCapital after increase: 10,400 thousand USD\nEquity ownership: 100\uff05","jir_meta_title":"Japan Lifeline: US subsidiary capital increase decision | September 2026","jir_meta_description":"Japan Lifeline conducts a capital increase for its US subsidiary JLL Med USA. Increase amount: 10 million USD; post-increase capital: 10.4 million USD; equity ownership: 100%. Impact for FY ending March 2027 expected to be minimal.","jir_og_title":"Japan Lifeline: US subsidiary capital increase decision | September 2026","jir_og_description":"To strengthen the US footprint, capital increase for JLL Med USA will be implemented. At present, the impact on the FY ending March 2027 is expected to be minimal.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9484,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"capital_policy","footnotes":""},"sector":[],"importance":[],"class_list":["post-122699","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n